Because paper logbooks are better at serving as kindling than reliable sample tracking solutions
Paper Logbooks Are So 1747
But that’s just not how we do things anymore.
In 1747 Dr. James Lind conducted the world’s first modern clinical trial, feeding sailors different foods and recording with pen and paper which foods had the most success at preventing scurvy.
Since 1747, we have developed vaccines to prevent horrible diseases, commercialized air flight, harnessed the power of nuclear technology, and sent men to the moon.
Yet almost 250 years later, at the height of the technology age, we are still using the same outdated data recording techniques as Dr. Lind.
It’s time for a better option.
Less Paper, More Blockhain
Paper logbooks are out. Smart tech is in.
At TruLab we are harnessing the power of blockchain technology to put smart tech to work. Our encrypted technology provides a secure and intelligent way to track samples throughout the clinical trial process.
Gone are the days of flipping through logbooks, searching for scribbles that might point clinical site managers towards a freezer a lost sample may be hiding in the back of.
TruLab’s solution allows for real-time tracking of samples for the entirety of the clinical trial, from collection to biobank. The best part for site managers? All of this real-time data is available instantaneously on users’ iPhones.
No More Drug Sponsors Breathing Down Your Neck
TruLab’s solution allows both drug sponsors and trial managers to track samples in real-time.
Our solution leaves all parties happy:
Sponors are able to access real-time data throughout the clinical trial process and receive higher quality data at the end of trials.
Clinical sites are able to swap paper logs for blockchain-powered smart tech.
Labs receive better sample management software that integrates directly into Lab Information Management Systems (LIMS).
CRO’s are able to monitor trials and perform real-time sample reconciliation at the site level.
TruLab’s solution just makes sense. Let’s work together to bring clinical trials into the 21st century.